Subclinical hyperthyroidism: Controversies in management

American Family Physician

Volumn 65, Issue 3, 2002, Pages 431-438

  Shrier, Diane K ^a   Burman, Kenneth D ^b  

^a GEORGE WASHINGTON UNIVERSITY MEDICAL CENTER   (United States)

^b WASHINGTON HOSPITAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHYROID AGENT; IODINE 131; LIOTHYRONINE; PROPYLTHIOURACIL; THIAMAZOLE; THYROTROPIN; THYROXINE;

ALGORITHM; CLINICAL FEATURE; DIAGNOSTIC PROCEDURE; DISEASE COURSE; FREE LIOTHYRONINE INDEX; FREE THYROXINE INDEX; GRAVES DISEASE; HORMONE BLOOD LEVEL; HUMAN; HYPERTHYROIDISM; NODULAR GOITER; REVIEW; THYROIDECTOMY; THYROTROPIN BLOOD LEVEL;

ALGORITHMS; BONE DENSITY; DIAGNOSIS, DIFFERENTIAL; GOITER, NODULAR; GRAVES DISEASE; HUMANS; HYPERTHYROIDISM; THYROID FUNCTION TESTS; THYROTROPIN;

EID: 0036471922     PISSN: 0002838X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (47)

1. Subclinical thyrotoxicosis
2. The incidence of thyroid disorders in the community: A twenty-year follow-up of the Whickham Survey
3. Low serum thyrotropin concentrations as a risk factor for atrial fibrillations in older persons
4. Subclinical thyroid disease: A clinician's perspective
5. Normalization of serum thyrotrophin by means of radioiodine treatment in subclinical hyperthyroidism: Effect on bone loss in postmenopausal women
6. Subclinical hyperthyroidism
7. Screening for thyroid disease: An update
8. Subclinical thyrotoxicosis
9. Elderly patients with suppressed serum TSH but normal free thyroid hormone levels usually have mild thyroid overactivity and are at increased risk of developing overt hyperthyroidism
10. Subclinical thyroid disease in the elderly
11. Screening for thyroid disease in a primary care unit with a thyroid stimulating hormone assay with a low detection limit
12. Prevalence and follow-up of abnormal thyrotropin (TSH) concentrations in the elderly in the United Kingdom
13. Subclinical thyroid disease
14. Subclinical hyperthyroidism-just a low serum thyrotropin concentration, or something more?
15. Thyroid dysfunction: How to manage overt and subclinical disease in older patients
16. Subclinical thyroid dysfunction
17. Subclinical hypothyroidism and hyperthyroidism in elderly subjects: Should they be treated?
18. Clinical and laboratory assessment of subclinical thyroid disease
19. Comparison of serum thyrotrophin concentrations determined by a third generation assay in patients with various types of overt and subclinical thyrotoxicosis
20. Changes in bone mass during prolonged subclinical hyperthyroidism due to L-thyroxine treatment: A meta-analysis
21. Thyroid dysfunction in adults over age 55 years. A study in an urban US community
22. Clinical significance of low serum thyrotropin concentration by chemiluminometric assay in 85-year-old women and men
23. Cardiac effects of long term thyrotropin-suppressive therapy with levothyroxine
24. Thyroid disease and its treatment: Short- and long-term consequences
25. Painless thyroiditis and transient hyperthyroidism without goiter
26. Hyperthyroidism
27. Clinical utility of assays for TSH receptor antibodies
28. Iodine-induced hyperthyroidism: Occurrence and epidemiology
29. Impaired cardiac reserve and exercise capacity in patients receiving long-term thyrotropin suppressive therapy with levothyroxine
30. Diastolic dysfunction in patients on thyroid-stimulating hormone suppressive therapy with levothyroxine: Beneficial effect of beta-blockade
31. Cardiac function, physical exercise capacity, and quality of life during long-term thyrotropin-suppressive therapy with levothyroxine: Effect of individual dose tailoring
32. Hyperthyroid heart disease
33. Biochemical markers of bone turnover in patients with thyroid dysfunctions and in euthyroid controls: A cross-sectional study
34. Effect of endogenous subclnical hyperthyroidism on bone metabolism and bone mineral density in premenopausal women
35. How serious are the risks of thyroid hormone over-replacement?
36. Prevalence of fractures in postmenopausal women with thyroid disease
37. Randomized trial of pamidronate in patients with thyroid cancer: Bone density is not reduced by suppressive doses of thyroxine, but is increased by cyclic intravenous pamidronate
38. The effect of thyroid hormone on skeletal integrity
39. Effect of replacement doses of thyroxine on bone mineral density
40. Effects on bone mass of long term treatment with thyroid hormones: A meta-analysis
41. Psychopathological and neuropsychological symptoms in patients with subclinical and remitted hyperthyroidism
42. Differences and similarities in the diagnosis and treatment of Graves' disease in Europe, Japan, and the United States
43. American Thyroid Association guidelines for detection of thyroid dysfunction
44. Clinical perspectives in the diagnosis of thyroid disease
45. Practice guidelines for the detection and management of thyroid dysfunction. A comparative review of the recommendations
46. Screening for subclinical thyroid disease